Kiaro Holdings Corp. announced that subject to the approval of the TSX Venture Exchange (the " TSXV "), the Company has appointed Mr. Jatinder Dhaliwal to its Board of Directors (the "Appointment") effective as of July
21, 2022. Mr. Jatinder Dhaliwal is a registered pharmacist, and has significant capital markets experience. Mr. Dhaliwal holds a Bachelor of Pharmacy from the University of British Columbia and a Bachelor of Science in
Biology from the University of Victoria. He has served as CEO and director of multiple publicly traded cannabis companies. He has served as a director of a licensed producer and extractor. He has extensive knowledge in
agricultural, medical and pharmaceutical operations. Mr. Dhaliwal is well versed in the cannabis market from seed to sale from cultivating, extracting, manufacturing, and distributing and quality control of cannabis
flower, oils, and concentrates. Mr. Dhaliwal is a certified medical cannabis practitioner. He has overseen operations of numerous retail and commercial operations and implemented various health protocols and technology
advances into health and wellness chains.